In vitro, in vivo and post explantation testing of glucose-detecting biosensors: Current methods and recommendations

Biomaterials

Volumn 28, Issue 25, 2007, Pages 3687-3703

  Koschwanez, Heidi E ^a   Reichert, William M ^a  

^a Duke University   (United States)

Author keywords

Biosensor; Foreign body response; In vitro test; In vivo test; wound healing

Indexed keywords

BIOCOMPATIBILITY; BIOTECHNOLOGY; IMPLANTS (SURGICAL); MEDICAL PROBLEMS; RELIABILITY;

FOREIGN BODY RESPONSE; IN VITRO TEST; IN VIVO TEST; WOUND HEALING;

GLUCOSE SENSORS;

BIOMATERIAL; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTIFICIAL PANCREAS; BIOCOMPATIBILITY; BIOSENSOR; CHORIOALLANTOIS; COST; CYTOTOXICITY; DEVICE; DIABETES CONTROL; DIABETES MELLITUS; EXPLANT; FOOD AND DRUG ADMINISTRATION; FOREIGN BODY; GLUCOSE BLOOD LEVEL; HUMAN; HYDRODYNAMICS; IMPLANT; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; IONTOPHORESIS; MEDICAL TECHNOLOGY; MICRODIALYSIS; MOLECULAR WEIGHT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REVIEW; SAFETY; SELF MONITORING; SENSOR; TEMPERATURE SENSITIVITY; WOUND HEALING;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE; EQUIPMENT DESIGN; GUIDELINES; HUMANS;

EID: 34249800911     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.03.034     Document Type: Review

References (108)

1. National diabetes fact sheet: general information and national estimates on diabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2005.
2. Petersen M. Economic costs of diabetes in the US in 2002. Diabetes Care 26 3 (2003) 917-932
3. Turner A.P.F., and Pickup J.C. Diabetes-mellitus-biosensors for research and management. Biosensors 1 1 (1985) 85-115
4. Lasker R.D. The diabetes control and complications trial-implications for policy and practice. New Engl J Med 329 14 (1993) 1035-1036
5. American diabetes association: clinical practice recommendations 1997-introduction. Diabetes Care 20 (1997) S1
6. Tests of glycemia in diabetes. Diabetes Care 25 90001 (2002) 97S-99S
7. Bloomgarden Z.T. Treatment issues in type 1 diabetes. Diabetes Care 25 1 (2002) 230-236
8. Fischer U. Fundamentals of glucose sensors. Diabetes Med 8 4 (1991) 309-321
9. Wilkins E., and Atanasov P. Glucose monitoring: state of the art and future possibilities. Med Eng Phys 18 4 (1996) 273-288
10. Gabbay R. New developments in home glucose monitoring: minimizing the pain. Can J Diabetes 27 3 (2003) 371-376
11. Tamada J.A., Garg S., Jovanovic L., Pitzer K.R., Fermi S., and Potts R.O. Noninvasive glucose monitoring-comprehensive clinical results. JAMA 282 19 (1999) 1839-1844
12. Pitzer K.R., Desai S., Dunn T., Edelman S., Jayalakshmi Y., Kennedy J., et al. Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care 24 5 (2001) 881-885
13. Cygnus Customer Service Representative. Telephone Conversation, 2004.
14. Press Release: FDA Clears New Diabetes Device for Marketing. US Department of Health and Human Services. US Food and Drug Administration, 2003.
15. Medtronic MiniMed. REAL-time continuous glucose monitoring. Northridge, CA: Medtronic MiniMed, Inc. [Company Product Information Web Page] 2006 [cited 2006]. Available from: 〈http://www.minimed.com/products/insulinpumps/components/cgm.html〉.
16. Medtronic MiniMed Customer Service Representative. Telephone Conversation, Northridge, CA, 2006.
17. Feldman B., Brazg R., Schwartz W., and Weinstein R. A continuous glucose sensor based on wired enzyme technology-results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 5 (2003) 769-779
18. Feldman B. The free-style navigator™ continuous glucose monitor: Complete results from a home-use trial. Diabetes Technol Ther 6 2 (2004) 218
19. Klonoff D.C. A review of continuous glucose monitoring technology. Diabetes Technol Ther 7 5 (2005) 770-775
20. Hullegie L.M., Lutgers H.L., Dullaart R.P.F., Sluiter W.J., Wientjes K.J., Schoonen A.J.M., et al. Effects of glucose and insulin levels on adipose tissue glucose measurement by microdialysis probes retained for three weeks in Type 1 diabetic patients. Netherlands J Med 57 1 (2000) 13-19
21. Lutgers H.L., Hullegie L.M., Hoogenberg K., Sluiter W.J., Dullaart R.P.F., Wientjes K.J., et al. Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in Type 1 diabetic patients. Netherlands J Med 57 1 (2000) 7-12
22. Gebhart S., Faupel M., Fowler R., Kapsner C., Lincoln D., McGee V., et al. Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneum. Diabetes Technol Ther 5 2 (2003) 159-166
23. Garg S.K., Schwartz S., and Edelman S.V. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27 3 (2004) 734-738
24. GlucoWatch approved for children with diabetes. FDA Consum 36 6 (2002) 6
25. Garg S.K., Potts R.O., Ackerman N.R., Fermi S.J., Tamada J.A., and Chase H.P. Correlation at fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 22 10 (1999) 1708-1714
26. Medtronic MiniMed Customer Service Representative. Telephone Conversation, Northridge, CA, 2007.
27. Reichert W.M., and Sharkawy A.A. Biosensors. In: von Recum A.F. (Ed). Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials (1999), Taylor & Francis, Philadelphia 439-459
28. Gerritsen M. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care 23 2 (2000) 143-145
29. Reichert W.M., and Saavedra S.S. Materials considerations in the selection, performance and adhesion of polymeric encapsulants for implantable sensors. In: Williams D.F. (Ed). Science and technology-a comprehensive treatment (1992) 303-343
30. Wisniewski N., Moussy F., and Reichert W.M. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 366 6-7 (2000) 611-621
31. Wisniewski N., and Reichert M. Methods for reducing biosensor membrane biofouling. Colloids Surf B-Biointerfaces 18 3-4 (2000) 197-219
32. Updike S.J., Shults M.C., Gilligan B.J., and Rhodes R.K. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 23 2 (2000) 208-214
33. Sharkawy A.A., Klitzman B., Truskey G.A., and Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. 1. Diffusion properties. J Biomed Mater Res 37 3 (1997) 401-412
34. Sharkawy A.A., Klitzman B., Truskey G.A., and Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res 40 4 (1998) 586-597
35. Sharkawy A.A., Klitzman B., Truskey G.A., and Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res 40 4 (1998) 598-605
36. Sieminski A.L., and Gooch K.J. Biomaterial-microvasculature interactions. Biomaterials 21 22 (2000) 2233-2241
37. Marshall A.J., Irvin C.A., Barker T., Sage E.H., Hauch K.D., and Ratner B.D. Biomaterials with tightly controlled pore size that promote vascular in-growth. Abstr Pap Am Chem Soc 228 (2004) U386
38. Norton L.W., Tegnell E., Toporek S.S., and Reichert W.M. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials 26 16 (2005) 3285-3297
39. Klueh U., Dorsky D.I., and Kreutzer D.L. Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials 26 10 (2005) 1155-1163
40. Gilligan B.J., Shults M.C., Rhodes R.K., and Updike S.J. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog-model. Diabetes Care 17 8 (1994) 882-887
41. Von Woedtke T., Rebrin K., Fischer U., Abel P., Wilke W., Vogt L., et al. In situ calibration of implanted electrochemical glucose sensors. Biomed Biochim Acta 48 11-12 (1989) 943-952
42. Voskerician G., Liu C.C., and Anderson J.M. Electrochemical characterization and in vivo biocompatibility of a thick-film printed sensor for continuous in vivo monitoring. IEEE Sensors J 5 6 (2005) 1147-1158
43. Kerner W., Kiwit M., Linke B., Keck F.S., Zier H., and Pfeiffer E.F. The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosensors Bioelectr 8 9-10 (1993) 473-482
44. Pickup J.C., Claremont D.J., and Shaw G.W. Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man. Acta Diabetol 30 3 (1993) 143-148
45. Clark Jr. L.C., Spokane R.B., Homan M.M., Sudan R., and Miller M. Long-term stability of electroenzymatic glucose sensors implanted in mice-an update. ASAIO J 34 (1988) 259-265
46. Fischer U., Hidde A., Herrmann S., Vonwoedtke T., Rebrin K., and Abel P. Oxygen-tension at the subcutaneous implantation site of glucose sensors. Biomed Biochim Acta 48 11-12 (1989) 965-971
47. Zhang Y., Bindra D.S., Barrau M.B., and Wilson G.S. Application of cell culture toxicity test to the development of implantable biosensors. Biosensor Bioelectr 6 (1991) 653-661
48. The biocompatibility of materials used in drug containers, medical devices, and implants. In: United States Pharmacopeial Convention, editor. United States pharmacopeia. Rockville, MD: United States Pharmacopeial Convention, 2002. p. 2091-8.
49. Biological evaluation of medical devices-Part 1: Guidance on selection of tests. ISO 10993-1:1992(E). International Organization for Standardization (ISO), 1992.
50. Standard practice for selecting generic biological test methods for materials and devices Designation F 748-98. American Society for Testing and Materials (ASTM), 2001.
51. Leuschner J. Legal requirements for the preclinical toxicological evaluation of biomaterials. Clin Mater 10 1-2 (1992) 51-57
52. Upman P. Testing. In: von Recum A.F. (Ed). Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials (1999), Taylor & Francis, Philadelphia 275-289
53. Armour J.C., Lucisano J.Y., McKean B.D., and Gough D.A. Application of chronic intravascular blood-glucose sensor in dogs. Diabetes 39 12 (1990) 1519-1526
54. Updike S.J., Shults M.C., Rhodes R.K., Gilligan B.J., Luebow J.O., and von Heimburg D. Enzymatic glucose sensors-improved long-term performance in vitro and in vivo. ASAIO J 40 (1994) 157-163
55. Bindra D.S., Zhang Y.N., Wilson G.S., Sternberg R., Thevenot D.R., Moatti D., et al. Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. Anal Chem 63 17 (1991) 1692-1696
56. von Woedtke T., Julich W.D., Hartmann V., Stieber M., and Abel P.U. Sterilization of enzyme glucose sensors: problems and concepts. Biosensors Bioelectr 17 5 (2002) 373-382
57. Biological evaluation of medical devices-Part 7: Ethylene oxide sterilization residuals 10993-7. International Organization for Standardization (ISO), 1995.
58. Sterilization and sterility assurance of compendial articles. In: United States Pharmacopeial Convention, editor. United States Pharmacopeia. Rockville, MD: United States Pharmacopeial Convention, 2002. p. 2250-5.
59. Abel P.U., and von Woedtke T. Biosensors for in vivo glucose measurement: can we cross the experimental stage. Biosensors Bioelectr 17 11-12 (2002) 1059-1070
60. Ohashi E., and Karube I. Development of a thin membrane glucose sensor using beta-type crystalline chitin for implantable biosensor. J Biotechnol 40 1 (1995) 13-19
61. Vering T., Adam S., Drewer H., Dumschat C., Steinkuhl R., Schulze A., et al. Wearable microdialysis system for continuous in vivo monitoring of glucose. Analyst 123 7 (1998) 1605-1609
62. Rebrin K., Fischer U., Vondorsche H.H., Von Woetke T., Abel P., and Brunstein E. Subcutaneous glucose monitoring by means of electrochemical sensors-fiction or reality. J Biomed Eng 14 1 (1992) 33-40
63. Johnson H.J., Northup S.J., Seagraves P.A., Atallah M., Garvin P.J., Lin L., et al. Biocompatibility test procedures for materials evaluation in vitro. 2. Objective methods of toxicity assessment. J Biomed Mater Res 19 5 (1985) 489-508
64. Ziegler M., Schlosser M., Abel P., and Ziegler B. Antibody-response in rats against nontoxic glucose sensor membranes tested in cell-culture. Biomaterials 15 10 (1994) 859-864
65. Schlosser M., and Ziegler M. Biocompatibility of active implantable devices. In: Fraser D.M. (Ed). Biosensors in the body-continuous in vivo monitoring (1997), Wiley, Chichester, West Sussex
66. Moattisirat D., Capron E., Poitout V., Reach G., Bindra D.S., Zhang Y., et al. Towards continuous glucose monitoring-in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue. Diabetologia 35 3 (1992) 224-230
67. Reach G., and Wilson G.S. Can continuous glucose monitoring be used for the treatment of diabetes. Anal Chem 64 6 (1992) A381-A386
68. Lucisano J.Y., and Gough D.A. Transient-response of the two-dimensional glucose sensor. Anal Chem 60 13 (1988) 1272-1281
69. Linke B., Kerner W., Kiwit M., Pishko M., and Heller A. Amperometric biosensor for in-vivo glucose sensing based on glucose-oxidase immobilized in a redox hydrogel. Biosensors Bioelectr 9 2 (1994) 151-158
70. Gerritsen M., Jansen J.A., Kros A., Vriezema D.M., Sommerdijk N., Nolte R.J.M., et al. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res 54 1 (2001) 69-75
71. Treloar P.H., Christie I.M., and Vadgama P.M. Engineering the right membranes for electrodes at the biological interface-solvent-cast and electropolymerized. Biosensors Bioelectr 10 1-2 (1995) 195-201
72. Taguchi S., Inaba T., Nishio M., Hata N., Kasahara I., and Goto K. Membrane filters for the concentration of trace-elements in water-distribution of ion-pairs between membrane-filter and aqueous phases. Analyst 114 4 (1989) 489-492
73. Schmidtke D.W., and Heller A. Accuracy of the one-point in vivo calibration of "wired" glucose oxidase electrodes implanted in jugular veins of rats in periods of rapid rise and decline of the glucose concentration. Anal Chem 70 10 (1998) 2149-2155
74. Moussy F., Jakeway S., Harrison D.J., and Rajotte R.V. In-vitro and in-vivo performance and lifetime of perfluorinated ionomer-coated glucose sensors after high-temperature curing. Anal Chem 66 22 (1994) 3882-3888
75. Moattisirat D., Velho G., and Reach G. Evaluating in vitro and in vivo, the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor. Biosensors Bioelectr 7 5 (1992) 345-352
76. Wilson G.S., and Gifford R. Biosensors for real-time in vivo measurements. Biosensors Bioelectr 20 12 (2005) 2388-2403
77. Wisniewski N., Rajamand N., Adamsson U., Lins P.E., Reichert W.M., Klitzman B., et al. Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol-Endocrinol Metabol 282 6 (2002) E1316-E1323
78. Ertefai S., and Gough D.A. Physiological preparation for studying the response of subcutaneously implanted glucose and oxygen sensors. J Biomed Eng 11 5 (1989) 362-368
79. Wagner J.G., Schmidtke D.W., Quinn C.P., Fleming T.F., Bernacky B., and Heller A. Continuous amperometric monitoring of glucose in a brittle diabetic chimpanzee with a miniature subcutaneous electrode. Proc Natl Acad Sci USA 95 11 (1998) 6379-6382
80. Gough D.A., Lucisano J.Y., and Tse P.H.S. Two-dimensional enzyme electrode sensor for glucose. Anal Chem 57 12 (1985) 2351-2357
81. Hopf H.W. Development of subcutaneous wound oxygen measurement in humans: contributions of Thomas K. Hunt, MD. Wound Repair Regeneration 11 6 (2003) 424-430
82. Fain J.A. Pump up your knowledge of insulin pumps. Nursing 33 6 (2003) 51-53
83. Ninikoski J., Heughan C., and Hunt T.K. Oxygen tension in human wounds. J Surg Res 12 (1972) 77-82
84. Lindner E., Cosofret V.V., Ufer S., Buck R.P., Kao W.J., Neuman M.R., et al. Ion-Selective membranes with low plasticizer content-electroanalytical characterization and biocompatibility studies. J Biomed Mater Res 28 5 (1994) 591-601
85. Marchant R., Hiltner A., Hamlin C., Rabinovitch A., Slobodkin R., and Anderson J.M. In vivo biocompatibility studies. 1. The cage implant system and a biodegradable hydrogel. J Biomed Mater Res 17 2 (1983) 301-325
86. Kao W.J., and Anderson J.M. The cage implant testing system. In: von Recum A.F. (Ed). Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials (1999), Taylor & Francis, Philadelphia 659-669
87. Kao W.Y.J., McNally A.K., Hiltner A., and Anderson J.M. Role for interleukin-4 in foreign-body giant-cell formation on a poly(etherurethane urea) in-vivo. J Biomed Mater Res 29 10 (1995) 1267-1275
88. Zhao Q., Topham N., Anderson J.M., Hiltner A., Lodoen G., and Payet C.R. Foreign-body giant-cells and polyurethane biostability-in vivo correlation of cell-adhesion and surface cracking. J Biomed Mater Res 25 2 (1991) 177-183
89. Papenfuss H.D., Gross J.F., Intaglietta M., and Treese F.A. Transparent access chamber for the rat dorsal skin fold. Microvasc Res 18 3 (1979) 311-318
90. Makale MT, Lin JT, Calou RE, Tsai AG, Chen PC, Gough DA. Tissue window chamber system for validation of implanted oxygen sensors, 2003.
91. Valdes T.I., Kreutzer D., and Moussy F. The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. J Biomed Mater Res 62 2 (2002) 273-282
92. Valdes T.I., Klueh U., Kreutzer D., and Moussy F. Ex ova chick chorioallantoic membrane as a novel in vivo model for testing biosensors. J Biomed Mater Res A 67A 1 (2003) 215-223
93. Dennis Jr. M.B. Protection of research animals. In: von Recum A.F. (Ed). Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials (1999), Taylor & Francis, Philadelphia 465-473
94. Shichiri M., Yamasaki Y., Nao K., Sekiya M., and Ueda N. In vivo characteristics of needle-type glucose sensor-measurements of subcutaneous glucose-concentrations in human volunteers. Hormone Metabol Res 20 (1988) 17-20
95. Mendenhall H.V. Animal selection. In: von Recum A.F. (Ed). Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials (1999), Taylor & Francis, Philadelphia 475-479
96. Hem A., Smith A.J., and Solberg P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 32 4 (1998) 364-368
97. Rosell S., and Belfrage E. Blood-circulation in adipose-tissue. Physiol Rev 59 4 (1979) 1078-1104
98. Rossi M., Lall K., Standfield N., and Dornhorst A. Impaired vasoconstriction of peripheral cutaneous blood flow in Type 1 diabetic patients following food ingestion. Diabetic Med 15 6 (1998) 463-466
99. Pamiesandreu E., Fiksenolsen M., Rizza R.A., and Romero J.C. High-fructose feeding elicits insulin-resistance without hypertension in normal mongrel dogs. Am J Hypertension 8 7 (1995) 732-738
100. Non-mouse models of diabetes complications in cardiovascular and microvascular diseases. National Institutes of Health (NIH). Bethesda, MD [Online government document] 2000 [cited 2007]. Available from: 〈http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-01-010.html〉.
101. Whitfield J. Fat pigs ape obese humans. Nature. New York, NY [Online journal] 2003 [cited 2003]. Available from: 〈www.nature.com/news〉.
102. Fischer U., Ertle R., Abel P., Rebrin K., Brunstein E., Vondorsche H.H., et al. Assessment of subcutaneous glucose-concentration-validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs. Diabetologia 30 12 (1987) 940-945
103. Velho G., Froguel P., Thevenot D.R., and Reach G. Strategies for calibrating a subcutaneous glucose sensor. Biomed Biochim Acta 48 11-12 (1989) 957-964
104. Gerritsen M., Jansen J.A., and Lutterman J.A. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Netherlands J Med 54 4 (1999) 167-179
105. Csoregi E., Schmidtke D.W., and Heller A. Design and optimization of a selective subcutaneously implantable glucose electrode based on wired glucose-oxidase. Anal Chem 67 7 (1995) 1240-1244
106. Yu B.Z., Long N., Moussy Y., and Moussy F. A long-term flexible minimally-invasive implantable glucose biosensor based on an epoxy-enhanced polyurethane membrane. Biosensors Bioelectr 21 12 (2006) 2275-2282
107. Standard practice for short-term screening of implant materials. Designation F 763-99. American Society for Testing and Materials (ASTM), 2001.
108. Brunstein E., Abel P., Gens A., Eich K., and Vonwoedtke T. Preparation and validation of implantable electrodes for the measurement of oxygen and glucose. Biomed Biochim Acta 48 11-12 (1989) 911-917